Publicacións en colaboración con investigadores/as de Centro de Investigación en Red en Enfermedades Cardiovasculares (46)

2022

  1. Challenges in managing patients with heart failure with reduced ejection fraction

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 1-7

  2. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis

    Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412

  3. Role of vericiguat in the overall etiopathogenesis of heart failure with reduced ejection fraction. Current position

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 8-14

  4. Sex Differences in Low-Density Lipoprotein Cholesterol Reduction with PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry

    Journal of Cardiovascular Pharmacology, Vol. 79, Núm. 4, pp. 523-529

  5. Therapeutic approach to patients with heart failure with reduced ejection fraction. The role of vericiguat

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 23-29

  6. Vericiguat: VICTORIA trial results

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 15-22

2021

  1. Constrictive pericarditis

    Medicine (Spain), Vol. 13, Núm. 43, pp. 2517-2531

  2. Debate: Refractory angina. The Reducer device as a new therapeutic approach. Perspective from the clinic

    REC: Interventional Cardiology

  3. Diagnostic protocol for constrictive pericarditis

    Medicine (Spain), Vol. 13, Núm. 43, pp. 2543-2547

  4. Diagnostic protocol for patients with pericarditis and fever

    Medicine (Spain), Vol. 13, Núm. 43, pp. 2548-2551

  5. Direct Oral Anticoagulants Versus Vitamin-K Antagonist After PCIs in Patients With AF: A Meta-analysis of Cardiac Ischemic Events

    Journal of cardiovascular pharmacology, Vol. 77, Núm. 2, pp. 164-169

  6. Impact of statins in patients with COVID-19

    Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 637-640

  7. Indications for pericardial biopsy

    Medicine (Spain), Vol. 13, Núm. 43, pp. 2552-2554

  8. Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48

  9. Mujer de 40 años con insuficiencia cardíaca derecha de novo y un corazón envuelto en una «corona de espinas»

    Medicine (Spain), Vol. 13, Núm. 43, pp. 2555.e1-2555.e4

  10. Neuromodulatory Approaches for Atrial Fibrillation Ablation

    European Cardiology Review , Vol. 16

  11. Pericardial effusion

    Medicine (Spain), Vol. 13, Núm. 43, pp. 2508-2516

  12. Protocolo diagnóstico y terapéutico del taponamiento cardíaco

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 43, pp. 2540-2542

  13. Recurrent pericarditis

    Medicine (Spain), Vol. 13, Núm. 43, pp. 2532-2539

  14. Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value

    Journal of Molecular Medicine, Vol. 99, Núm. 12, pp. 1741-1753